ticks

“red-meat-allergy”-from-tick-bites-is-spreading-both-in-us-and-globally

“Red meat allergy” from tick bites is spreading both in US and globally


Remember to check for ticks after your next stroll through the woods or long grasses.

Hours after savoring that perfectly grilled steak on a beautiful summer evening, your body turns traitor, declaring war on the very meal you just enjoyed. You begin to feel excruciating itchiness, pain, or even swelling that can escalate to the point of requiring emergency care.

The culprit isn’t food poisoning—it’s the fallout from a tick bite you may have gotten months earlier and didn’t even notice.

This delayed allergic reaction is called alpha-gal syndrome. While it’s commonly called the “red meat allergy,” that nickname is misleading, because alpha-gal syndrome can cause strong reactions to many products, beyond just red meat.

The syndrome is also rapidly spreading in the US and around the globe. The Centers for Disease Control and Prevention estimates as many as 450,000 people in the US may have it. And it’s carried by many more tick species than most people realize.

Map showing alpha-gal syndrome prevalence.

Cases of suspected alpha-gal syndrome based on confirmed laboratory evidence.

Credit: CDC

Cases of suspected alpha-gal syndrome based on confirmed laboratory evidence. Credit: CDC

What is alpha-gal syndrome?

Alpha-gal syndrome is actually an allergy to a sugar molecule with a tongue-twisting name: galactose-alpha-1,3-galactose, shortened to alpha-gal.

The alpha-gal sugar molecule exists in the tissues of most mammals, including cows, pigs, deer, and rabbits. But it’s absent in humans. When a big dose of alpha-gal gets into your bloodstream through a tick bite, it can send your immune system into overdrive to generate antibodies against alpha-gal. In later exposure to foods containing alpha-gal, your immune system might then launch an inappropriate allergic response.

Picture of lone star tick

A lone star tick (Amblyomma americanum). The tick can cause alpha-gal syndrome as well as carry other diseases, including ehrlichiosis, tularemia, and Southern tick-associated rash illness.

A lone star tick (Amblyomma americanum). The tick can cause alpha-gal syndrome as well as carry other diseases, including ehrlichiosis, tularemia, and Southern tick-associated rash illness. Credit: wildpixel/Getty

Often this allergy is triggered by eating red meat. But the allergy also can be set off by exposure to a range of other animal-based products, including dairy products, gelatin (think Jell-O or gummy bears), medications, and even some personal care items. The drug heparin, used to prevent blood clotting during surgery, is extracted from pig intestines, and its use has triggered a dangerous reaction in some people with alpha-gal syndrome.

Once you have alpha-gal syndrome, it’s possible to get over the allergy if you can modify your diet enough to avoid triggering another reaction for a few years and also avoid more tick bites. But that takes time and careful attention to the less obvious triggers that you might be exposed to.

Why more people are being diagnosed

As an entomologist who studies bugs and the diseases they transmit, what I find alarming is how rapidly this allergy is spreading around the globe.

Several years ago, experts thought alpha-gal syndrome was primarily limited to the Southeastern US because it was largely associated with the geographical range of the lone star tick.

photo of tick feeding on human

How a tick feeds.

However, both local and global reports have now identified many different tick species across six continents that are capable of causing alpha-gal syndrome, including the prolific black-legged tick, or deer tick, which also transmits Lyme disease.

These ticks lurk in yards and urban parks, as well as forests where they can stealthily grab onto hikers when they touch tick-infested vegetation. As tick populations boom with growing deer and human populations, the number of people with alpha-gal syndrome is escalating.

Why ticks are blamed for alpha-gal syndrome

There are a few theories on how a tick bite triggers alpha-gal syndrome and why only a small proportion of people bitten develop the allergy. To understand the theories, it helps to understand what happens as a tick starts feeding on you.

When a tick finds you, it typically looks for a warm, dark area to hide and attach itself to your body. Then its serrated teeth chew through your skin with rapid sawing motions.

As it excavates deeper into your skin, the tick deploys a barbed feeding tube, like a miniature drilling rig, and it secretes a biological cement that anchors its head into its new tunnel.

A tick’s mouth is barbed so it can stay embedded in your skin as it draws blood over hours and sometimes days.

Credit: National Institute of Allergy and Infectious Diseases

A tick’s mouth is barbed so it can stay embedded in your skin as it draws blood over hours and sometimes days. Credit: National Institute of Allergy and Infectious Diseases

Once secure, the tick activates its pumping station, injecting copious amounts of saliva containing anesthetics, blood thinners, and, sometimes, alpha-gal sugars into the wound so it can feed undetected, sometimes for days.

One theory about how a tick bite causes alpha-gal syndrome is linked to the enormous quantity of tick saliva released during feeding, which activates the body’s strong immune response. Another suggests how the skin is damaged as the tick feeds and the possible effect of the tick’s regurgitated stomach contents into the bite site are to blame. Or it may be a combination of these and other triggers. Scientists are still investigating the causes.

What an allergic reaction feels like

The allergy doesn’t begin right away. Typically, one to three months after the sensitizing tick bite, a person with alpha-gal syndrome has their first disturbing reaction.

Alpha-gal syndrome produces symptoms that range from hives or swelling to crushing abdominal pain, violent nausea, or even life-threatening anaphylactic shock. The symptoms usually start two to six hours after a person has ingested a meat product containing alpha-gal.

Due to a general lack of awareness about the allergy, however, doctors can easily miss the diagnosis. A study in 2022 found that 42 percent of US health care practitioners had never heard of alpha-gal syndrome. A decade ago, people with alpha-gal syndrome might go years before the cause of their symptoms was accurately diagnosed. Today, the diagnosis is faster in areas where doctors are familiar with the syndrome, but in many parts of the country it can still take time and multiple doctor visits.

Unfortunately, with every additional tick bite or exposure to food or products containing alpha-gal, the allergy can increase in severity.

Chart showing tick relative sizes

The lone star tick isn’t the only one that can cause alpha-gal syndrome. Black-legged ticks have also been connected to cases.

Credit: US Army

The lone star tick isn’t the only one that can cause alpha-gal syndrome. Black-legged ticks have also been connected to cases. Credit: US Army

If you think you have alpha-gal syndrome

If you suspect you may have alpha-gal syndrome, the first step is to discuss the possibility with your doctor and ask them to order a simple blood test to measure whether your immune system is reacting to alpha-gal.

If you test positive, the main strategy for managing the allergy is to avoid eating any food product from a mammal, including milk and cheese, as well as other potential triggers, such as more tick bites.

Read labels carefully. Some products contain additives such as carrageenan, which is derived from red algae and contains alpha-gal.

In extreme cases, people with alpha-gal syndrome may need to carry an EpiPen to prevent anaphylactic shock. Reputable websites, such as the CDC and alphagalinformation.org, can provide more information and advice.

Mysteries remain as alpha-gal syndrome spreads

Since alpha-gal syndrome was first formally documented in the early 2000s, scientists have made progress in understanding this puzzling condition. Researchers have connected the allergy to specific tick bites and found that people with the allergy can have a higher risk of heart disease, even without allergy symptoms.

But important mysteries remain.

Scientists are still figuring out exactly how the tick bite tricks the human immune system and why tick saliva is a trigger for only some people. With growing public interest in alpha-gal syndrome, the next decade could bring breakthroughs in preventing, diagnosing, and treating this condition.

For now, the next time you are strolling in the woods or in long grasses, remember to check for ticks on your body, wear long sleeves, long pants, and tick repellent to protect yourself from these bloodthirsty hitchhikers. If you do get bitten by a tick, watch out for odd allergic symptoms to appear a few hours after your next steak or handful of gummy bears.

Lee Rafuse Haines is associate research professor of molecular parasitology and medical entomology at University of Notre Dame.

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Photo of The Conversation

The Conversation is an independent source of news and views, sourced from the academic and research community. Our team of editors work with these experts to share their knowledge with the wider public. Our aim is to allow for better understanding of current affairs and complex issues, and hopefully improve the quality of public discourse on them.

“Red meat allergy” from tick bites is spreading both in US and globally Read More »

tick-killing-pill-shows-promising-results-in-human-trial

Tick-killing pill shows promising results in human trial

Ticked off —

Should it pan out, the pill would be a new weapon against Lyme disease.

A tick on a human

If you have a dog or cat, chances are you’ve given your pet a flavored chewable tablet for tick prevention at some point. What if you could take a similar pill to protect yourself from getting Lyme disease?

Tarsus Pharmaceuticals is developing such a pill for humans—minus the tasty flavoring—that could provide protection against the tick-borne disease for several weeks at a time. In February, the Irvine, California–based biotech company announced results from a small, early-stage trial showing that 24 hours after taking the drug, it can kill ticks on people, with the effects lasting for up to 30 days.

“What we envision is something that would protect you before the tick would even bite you,” says Bobby Azamian, CEO of Tarsus.

Lyme disease is a fast-growing problem in the United States, where approximately 476,000 people are diagnosed and treated for it each year, according to the most recent data from the Centers for Disease Control and Prevention. That number is likely an overestimate, because many patients are treated after a tick bite even if an infection isn’t confirmed, but it underscores the burden of Lyme disease on the health care system—which researchers at the CDC and Yale University put at nearly $1 billion per year.

The disease is caused by the bacteria Borrelia burgdorferi, which gets passed to humans through the bite of an infected tick. In most cases, a tick has to be attached for around 36 to 48 hours before the bacteria can be transmitted. Symptoms include fever, headache, fatigue, and a characteristic skin rash that looks like a bullseye.

Without a vaccine for Lyme disease on the market, current prevention includes using insect repellents such as DEET and permethrin and wearing closed shoes, long pants, and long sleeves when in a tick-infested area.

“We’ve seen increasing rates of tick-borne diseases over the years, despite being told to do tick checks, use DEET, and impregnate your clothes with permethrin,” says Paul Auwaerter, a professor of medicine at the Johns Hopkins University School of Medicine who studies Lyme disease.

A more effective treatment strategy would be welcome, Auwaerter says, especially because Lyme disease can sometimes cause serious health issues. Antibiotics are usually effective when taken early, although about 5 to 10 percent of patients can have lingering symptoms for weeks or months. If left untreated, the infection can spread to the joints and cause arthritis. It can also become established in the heart and nervous system, causing persistent fatigue, numbness, or weakness.

The experimental pill that Tarsus Pharmaceuticals is testing is a formulation of lotilaner, a drug that paralyzes and kills parasites by interfering with the way that signals are passed between their nerve cells. Lotilaner is already approved as a veterinary medicine under the brand name Credelio to control fleas and ticks in dogs and cats.

“Our animals have better options than we do for tick prevention,” says Linden Hu, a professor of immunology at Tufts Medical School who led the Tarsus trial. “There are quite a few drugs and vaccines available for dogs and cats, but there’s nothing for us.”

Tarsus first developed lotilaner for human use as an eye drop to treat blepharitis, or inflammation of the eyelid, which is caused by tiny mites. That drug, Xdemvy, was approved by the US Food and Drug Administration in July 2023. It stuns and kills mites present in the eyelid. Azamian and his team had the idea to test it against ticks in people. The oral version of the drug enters the bloodstream and is passed to a tick when it bites and starts sucking blood.

“A lot of drugs are tested in animals, but very few are commercialized for animal use and then go to human use,” Azamian says.

In a Phase II trial, 31 healthy adults took either a low or high dose of the Tarsus pill, or a placebo. Researchers then placed sterile ticks on participants’ arms and, 24 hours later, measured how many died. They also observed tick death 30 days after a single dose of the pill. At day one, 97 percent of ticks in the high-dose group and 92 percent in the low-dose group had died, while only 5 percent of ticks in the placebo group had. One month out, both doses of the pill killed around 90 percent of ticks. The company reported no serious adverse events from the pill, and none of the participants dropped out due to side effects.

“The takeaway is that it killed the ticks really quickly,” Hu says. “And the effect lasted for a long time.”

The fact that the drug targets ticks, rather than the bacteria that causes Lyme disease, means that it could protect against other tick-borne diseases that are spreading in the US, including babesiosis and anaplasmosis. Thanks to climate change and exploding deer populations, ticks are expanding their ranges—and carrying diseases with them.

Tarsus has not proven that its pill can actually prevent Lyme disease. That will require testing the drug in hundreds of people who are at high risk of contracting the disease. But Hu is cautiously optimistic: “This pill is potentially a pre-exposure prophylaxis that you don’t have to think about.”

Azamian imagines it as something people would take before going hiking or on a camping trip or just going outside in any tick-infested area.

“There is that subset of people that truly have persistent symptoms after Lyme disease that can really be devastating,” Auwaerter says, “so preventing that would be an amazing opportunity.”

This story originally appeared on wired.com.

Tick-killing pill shows promising results in human trial Read More »